South Africa’s Push for Local Lenacapavir...

By João L. Carapinha

March 5, 2026

South Africa has launched a bold bid to enable local lenacapavir production, targeting the twice-yearl...

BIC LEN HIV Treatment: New Single-Tablet Regimen Shows Promising Results in A...

South Africa Health Reform: Navigating Innovations and Challenges for 2026

mRNA Vaccine Advancements: Transforming Infectious Disease Prevention and Equity

Positive ARTISTRY-2 Trial Results for BIC LEN HIV Regimen

HIV Therapy Advancements: Promising Results from Bictegravir/Lenacapavir Comb...

Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...

Cabotegravir HIV Prevention: First Injectable PrEP Recommended for High-Risk ...

ViiV Healthcare Licensing: Expanding Access to Long-Acting HIV Treatment in L...

ARVs Water Impact: Examining the Environmental Consequences of Antiretroviral...

Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Acc...

FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Pr...

Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies